VPS9D1-AS1
gene geneOn this page
Also known as MYUFAISL
Summary
VPS9D1-AS1 (VPS9D1 antisense RNA 1, HGNC:48915) is a long non-coding RNA gene on chromosome 16q24.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48915 |
| Approved symbol | VPS9D1-AS1 |
| Name | VPS9D1 antisense RNA 1 |
| Location | 16q24.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | MYU, FAISL |
| Ensembl gene | ENSG00000261373 |
| Ensembl biotype | lncRNA |
| Entrez | 100128881 |
| RNAcentral | URS000003F392 — lncRNA, 1753 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 lncRNA
ENST00000562298, ENST00000562866
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000562298 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002580482 | 89716528 | 89716637 |
| ENSE00002593595 | 89717344 | 89718164 |
Expression profiles
Bgee: expression breadth ubiquitous, 154 present calls, max score 89.57.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.8283 / max 192.1120, expressed in 1296 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 155639 | 9.8239 | 1217 |
| 155638 | 2.6185 | 963 |
| 155640 | 0.3859 | 204 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 89.57 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.74 | gold quality |
| right uterine tube | UBERON:0001302 | 78.89 | gold quality |
| esophagus mucosa | UBERON:0002469 | 77.36 | gold quality |
| granulocyte | CL:0000094 | 77.25 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 75.76 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 74.37 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 73.81 | gold quality |
| left adrenal gland | UBERON:0001234 | 73.26 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.21 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 72.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 72.49 | gold quality |
| cerebellar cortex | UBERON:0002129 | 72.43 | gold quality |
| bone marrow cell | CL:0002092 | 72.37 | silver quality |
| right adrenal gland | UBERON:0001233 | 72.19 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 71.79 | gold quality |
| right lobe of liver | UBERON:0001114 | 71.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 71.37 | gold quality |
| adrenal cortex | UBERON:0001235 | 71.08 | gold quality |
| monocyte | CL:0000576 | 70.82 | gold quality |
| body of pancreas | UBERON:0001150 | 70.79 | gold quality |
| cerebellum | UBERON:0002037 | 70.76 | gold quality |
| spleen | UBERON:0002106 | 70.70 | gold quality |
| adrenal gland | UBERON:0002369 | 70.59 | gold quality |
| left ovary | UBERON:0002119 | 70.58 | gold quality |
| leukocyte | CL:0000738 | 70.47 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 70.46 | gold quality |
| right ovary | UBERON:0002118 | 70.42 | gold quality |
| adenohypophysis | UBERON:0002196 | 70.09 | gold quality |
| pituitary gland | UBERON:0000007 | 69.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.78 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 11)
- the MYU/hnRNP-K/CDK6 pathway functions downstream of Wnt/c-Myc signaling and plays a critical role in the proliferation and tumorigenicity of colon cancer cells. (PMID:27568568)
- Data suggest that downregulated long non-coding RNA VPS9D1-AS1 may be used as a prognosis predictor of gastric cancer. (PMID:29036784)
- Overexpression of VPS9D1-AS1 serves as a promising biomarker to predict the prognosis of non-small cell lung cancer. (PMID:30119235)
- Study demonstrated that lncRNA MYU functions as an oncogene in prostate cancer at least in part through the miR-184/c-Myc axis. (PMID:30132573)
- ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D. (PMID:31918265)
- LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion. (PMID:32808668)
- The lncRNA VPS9D1-AS1 Promotes Hepatocellular Carcinoma Cell Cycle Progression by Regulating the HuR/CDK4 Axis. (PMID:34558987)
- VPS9D1-AS1 gene rs7206570 polymorphism associated with the clinical stage of colorectal cancer and binding with hsa-miR-361-3p. (PMID:35022999)
- Long non-coding RNA MYU promotes ovarian cancer cell proliferation by sponging miR-6827-5p and upregulating HMGA1. (PMID:36776216)
- LncRNA VPS9D1-AS1 regulates miR-187-3p/fibroblast growth factor receptor-like 1 axis to promote proliferation, migration, and invasion of prostate cancer cells. (PMID:37929340)
- Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis. (PMID:38953363)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.